.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the province of Alberta, Stigma Grow has shown notable consistency and some positive movement in the cannabis market. In the Capsules category, they maintained a strong position, fluctuating slightly between the 3rd and 4th ranks over the span from August to November 2025. This suggests a stable demand and consumer trust in their capsule products. In the Concentrates category, Stigma Grow has made a significant leap from 14th place to 10th place by November, indicating a growing preference or strategic improvement in this product line. However, in the Flower category, they were not ranked in the top 30, which might suggest a need for better market penetration or product differentiation in this segment.
British Columbia presents a different landscape for Stigma Grow. In the Capsules category, they emerged in the rankings in October at 9th place, which could indicate a new or improved product offering that resonated well with consumers. The Concentrates category, however, shows a more volatile performance, with rankings dropping to 27th in October but recovering to 21st by November. This fluctuation might reflect competitive pressures or shifts in consumer preferences. In Ontario, the brand has maintained a relatively stable presence in the Capsules category, oscillating between 9th and 11th place, which suggests a consistent consumer base. However, their absence from the top 30 in the Concentrates category after August could indicate challenges in maintaining market share or visibility.
Competitive Landscape
In the Alberta concentrates market, Stigma Grow has shown a notable upward trend in its rankings, moving from 14th place consistently from August to October 2025, to breaking into the top 10 by November 2025. This improvement in rank is indicative of a positive shift in sales performance, as Stigma Grow's sales figures increased from September to November, contrasting with the decline observed in competitors like Lord Jones, which fell from 6th to 11th place, and Astro Lab, which dropped from 9th to 12th place over the same period. Meanwhile, Vortex Cannabis Inc. maintained a relatively stable position, ranking just above Stigma Grow in November. Interestingly, Headstone Cannabis made a significant leap from outside the top 20 to 8th place, suggesting a highly competitive landscape. Stigma Grow's ability to climb the ranks amidst these shifts highlights its growing presence and potential to capture more market share in Alberta's concentrates category.
Notable Products
In November 2025, Phoenix Tears RSO 1g from Stigma Grow reclaimed its top spot in the Concentrates category, achieving the highest sales figure of 3556 units. Indica RSO Capsules 25-Pack, which led in October, dropped to second place with a notable decline in sales to 2782 units. CBD Softgels 15-Pack maintained a consistent third place in the Capsules category across the months, showing a significant sales increase to 662 units in November. Phoenix Tears Honey Oil debuted in the rankings and secured the fourth position in Concentrates. Meanwhile, Phoenix Tears Resin dropped slightly to fifth place, continuing its trend of declining sales over the past months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
